Glomerular Diseases in Children.

Unique challenges exist in the diagnosis and treatment of glomerular diseases with their onset during childhood. Mounting evidence supports the notion that earlier onset cases occur due to larger numbers of genetic risk alleles. Nearly all causes of adult-onset glomerulonephritis, nephrotic syndrome, and thrombotic microangiopathy have also been described in children, although the prevalence of specific causes differs. Postinfectious glomerulonephritis, Henoch-Schönlein purpura nephritis, and minimal change disease remain the most common causes of glomerular disease in younger children in the United States and can be diagnosed clinically without need for biopsy. IgA nephropathy is the most common pediatric glomerular disease diagnosed by kidney biopsy and is considered the most common chronic glomerulopathy worldwide. In both developing and developed countries, there is a strong relationship between infectious diseases and nephritis onset or relapse. Although research has led to a better understanding of how to classify and manage glomerular diseases in children, the need for disease-specific biomarkers of activity and chronicity remains a hurdle. The strength of the immune system and the growth and maturation that occurs during adolescence are unique and require age-specific approaches to disease management.

[1]  J. Pfeifer,et al.  Routine Use of Clinical Exome-Based Next Generation Sequencing for Evaluation of Patients with Thrombotic Microangiopathies , 2017, Modern Pathology.

[2]  D. Foell,et al.  Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis , 2017, Arthritis & rheumatology.

[3]  Mark Haas,et al.  Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. , 2017, Kidney international.

[4]  R. Coppo Biomarkers and targeted new therapies for IgA nephropathy , 2017, Pediatric Nephrology.

[5]  Graham M Lord,et al.  Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. , 2017, Kidney international.

[6]  A. Shimizu,et al.  M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy , 2017, Pediatric Nephrology.

[7]  J. Kopp,et al.  Focal Segmental Glomerulosclerosis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[8]  H. Brunner,et al.  Advances in the care of children with lupus nephritis , 2017, Pediatric Research.

[9]  F. Emma,et al.  Minimal Change Disease. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[10]  D. Salant,et al.  An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[11]  P. Merkel,et al.  Patient-Reported Outcomes in Glomerular Disease. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[12]  S. Marks,et al.  Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management , 2017, Pediatric Nephrology.

[13]  M. Moxey-Mims,et al.  Glomerular Diseases: Registries and Clinical Trials. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[14]  M. Kretzler,et al.  Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[15]  A. Kitching,et al.  The Players: Cells Involved in Glomerular Disease. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[16]  C. Nester,et al.  Introduction: Glomerular Disease Update for the Clinician. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[17]  D. Salant,et al.  Membranous Nephropathy: A Journey From Bench to Bedside. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  B. Rovin,et al.  Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults , 2016, Arthritis care & research.

[19]  Jai Radhakrishnan,et al.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. , 2016, Journal of the American Society of Nephrology : JASN.

[20]  D. Kolbe,et al.  High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies. , 2016, Journal of the American Society of Nephrology : JASN.

[21]  Friedhelm Hildebrandt,et al.  Exploring the genetic basis of early-onset chronic kidney disease , 2016, Nature Reviews Nephrology.

[22]  M. Schiffer,et al.  Podocyte directed therapy of nephrotic syndrome—can we bring the inside out? , 2016, Pediatric Nephrology.

[23]  R. Vasan,et al.  Predicting decline of kidney function in lupus nephritis using urine biomarkers , 2016, Lupus.

[24]  B. Rovin,et al.  Validation of the Lupus Nephritis Clinical Indices in Childhood‐Onset Systemic Lupus Erythematosus , 2016, Arthritis care & research.

[25]  R. Lifton,et al.  Mutations in nuclear pore genes NUP93, NUP205, and XPO5 cause steroid resistant nephrotic syndrome , 2016, Nature Genetics.

[26]  J. Lieske,et al.  Complete Remission in the Nephrotic Syndrome Study Network. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[27]  A. Ryo,et al.  Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome. , 2015, American journal of human genetics.

[28]  P. Zipfel,et al.  Atypical aHUS: State of the art. , 2015, Molecular immunology.

[29]  Margaret Y. Nettleton,et al.  KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. , 2015, The Journal of clinical investigation.

[30]  S. Engelmann,et al.  A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. , 2015, Journal of the American Society of Nephrology : JASN.

[31]  S. Wenderfer,et al.  Viral-associated glomerulopathies in children , 2015, Pediatric Nephrology.

[32]  S. Levy,et al.  Defects of CRB2 cause steroid-resistant nephrotic syndrome. , 2015, American journal of human genetics.

[33]  C. Alpers,et al.  Glomerular disease: looking beyond pathology. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[34]  A. Sinha,et al.  Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. , 2014, Kidney international.

[35]  F. Hildebrandt,et al.  Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[36]  I. Bruce,et al.  Treat-to-target in systemic lupus erythematosus: recommendations from an international task force , 2014, Annals of the rheumatic diseases.

[37]  S. Sethi Etiology-based diagnostic approach to proliferative glomerulonephritis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  V. D’Agati,et al.  C3 glomerulopathy: consensus report , 2013, Kidney international.

[39]  E. Messias,et al.  Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies , 2013, Modern Pathology.

[40]  L. Rostaing,et al.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[41]  M. Ognjanović,et al.  Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[42]  Jie Ding,et al.  Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. , 2013, Journal of the American Society of Nephrology : JASN.

[43]  S. Özen,et al.  Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS) , 2012, Annals of the rheumatic diseases.

[44]  F. Fervenza,et al.  Membranoproliferative glomerulonephritis--a new look at an old entity. , 2012, The New England journal of medicine.

[45]  V. D’Agati,et al.  Focal segmental glomerulosclerosis. , 2011, The New England journal of medicine.

[46]  D. de Zeeuw,et al.  CKD treatment: time to alter the focus to albuminuria? , 2011, Advances in chronic kidney disease.

[47]  G. Remuzzi,et al.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[48]  M. Haas Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis. , 2009, Archives of pathology & laboratory medicine.

[49]  刘双信,et al.  Membranous nephropathy , 2008 .

[50]  B. Rodriguez-Iturbe,et al.  Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. , 2007, Kidney international.

[51]  L. Peruzzi,et al.  IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. , 2007, Journal of the American Society of Nephrology : JASN.

[52]  F. Hildebrandt,et al.  Nephrotic Syndrome in the First Year of Life: Two Thirds of Cases Are Caused by Mutations in 4 Genes (NPHS1, NPHS2, WT1, and LAMB2) , 2007, Pediatrics.

[53]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[54]  G. Ardissino,et al.  Epidemiology of chronic renal failure in children: data from the ItalKid project. , 2003, Pediatrics.

[55]  J. Haymann,et al.  Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. , 2002, The New England journal of medicine.

[56]  R. J. Hogg Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. A report of the Southwest Pediatric Nephrology Study Group. , 1983, Kidney international.